These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 895010)

  • 21. Mechanism of lung tumour colony reduction caused by coumarin anticoagulation.
    Hilgard P; Maat B
    Eur J Cancer (1965); 1979 Feb; 15(2):183-7. PubMed ID: 436894
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of guar an phenprocoumon concentration in serum and on coagulation reaction parameters of orally administered phenprocoumon].
    Kasper H; Barthel S; Feldmann K; Trobisch H; Schrezenmeir J
    Beitr Infusionther Klin Ernahr; 1983; 12():56-60. PubMed ID: 6316918
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lead concentration in blood during treatment with coumarin derivatives].
    Fischer H; Wehran HI
    Z Arztl Fortbild (Jena); 1978 Mar; 72(5):211. PubMed ID: 418581
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heparin and phenprocoumon].
    Deutsch E
    Dtsch Med Wochenschr; 1978 Mar; 103(12):496. PubMed ID: 639670
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
    Weber E; Walter E; Pfleiderer T
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.
    Kopera H; Schenk H; Stulemeijer S
    Eur J Clin Pharmacol; 1978 Jul; 13(5):351-6. PubMed ID: 27373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of diazepam (valium) on the effect of phenprocoumon (marcumar) (author's transl)].
    Schunter C; Held H; Schmülling R
    Klin Wochenschr; 1978 Mar; 56(6):305-7. PubMed ID: 642402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
    Spahn H; Kirch W; Mutschler E; Ohnhaus EE; Kitteringham NR; Lögering HJ; Paar D
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):97S-102S. PubMed ID: 6743480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coumarin therapy during antirheumatism therapy with sulindac].
    Schenk H; Klein G; Haralambus I; Goebel R
    Z Rheumatol; 1980; 39(3-4):102-8. PubMed ID: 6968485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of bezafibrate on the fibrinolytic enzyme system and the drug interaction with racemic phenprocoumon.
    Zimmermann R; Ehlers W; Walter E; Hoffrichter A; Lang PD; Andrassy K; Schlierf G
    Atherosclerosis; 1978 Apr; 29(4):477-85. PubMed ID: 666891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual variation in the response to phenprocoumon.
    Husted S; Andreasen F
    Eur J Clin Pharmacol; 1977; 11(5):351-8. PubMed ID: 880974
    [No Abstract]   [Full Text] [Related]  

  • 33. [Observations in phenprocoumon (Marcumar) poisoning. Elimination and serum binding of the anticoagulant atatoxic blood concentration].
    Held H; von Busse G; Meissner J
    Dtsch Med Wochenschr; 1980 Jun; 105(24):860-3. PubMed ID: 7418621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognosis in patients with cerebral ischemia treated with short term anticoagulant therapy -- a controlled trial (author's transl)].
    Gallhofer B; Ladurner G; Lechner H
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Aug; 48(8):409-14. PubMed ID: 6902691
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interactions between phenprocoumon (Marcumar) and drug-catabolizing, enzyme system-inducing pharmaceutic agents].
    Heni N; Völger R; Glogner P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1579-82. PubMed ID: 347786
    [No Abstract]   [Full Text] [Related]  

  • 36. [A study on interactions between pirprofen and phenprocoumon].
    Marbet GA; Duckert F; Schönenberger PM
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):207-9. PubMed ID: 3872834
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment with anticoagulants in glomerulonephritis (author's transl)].
    Girndt J
    Med Klin; 1979 Nov; 74(47):1767-71. PubMed ID: 522818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on possible interactions between tiaprofenic acid and phenprocoumon (author's transl)].
    Dürr J; Pfeiffer MH; Penth B; Wetzelsberger K; Lücker PW
    Arzneimittelforschung; 1981; 31(12):2163-7. PubMed ID: 7199320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjustment of phenprocoumon dosage utilizing a pharmacokinetic model.
    Böhm K; Vogel G; Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):141-6. PubMed ID: 2459009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulant therapy for radiation necrosis.
    Berlit P
    J Neurosurg; 1985 Apr; 62(4):625-6. PubMed ID: 3973739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.